Skip to main content
. Author manuscript; available in PMC: 2021 Feb 3.
Published in final edited form as: Behav Brain Res. 2019 Nov 4;379:112340. doi: 10.1016/j.bbr.2019.112340

Figure 1. RMTg infusions of the M3 muscarinic receptor antagonist 4-DAMP increase locomotor activation but do not lead to the acquisition of conditioned place preference.

Figure 1.

A. Bilateral RMTg injection sites for mice used in 4-DAMP CPP studies (n = 5). B. RMTg 4-DAMP infusions do not lead to the acquisition of conditioned place preference. C. By contrast, in the same mice locomotor activity measured within the RMTg 4-DAMP infusion conditioning chamber is significantly greater than locomotor activity measured within the RMTg vehicle infusion conditioning chamber (** p < 0.01 [4-DAMP vs. vehicle conditioning chambers]). All error bars represent ±SEM.